ITGAM and acute myeloid leukemia: The ligand-induced differentiation involved the AML stem/progenitor cells and was characterized by increased levels of CD11b, CD14 and CD15, as well as morphological signs of differentiation (i.e., altered nuclear morphology) and decreased AML cell proliferation.